ArticlemedRxiv : the preprint server for health sciences2026
A novel plasma proteomic signature predicts long-term incident heart failure risk among persons living with HIV.
Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Persons with HIV (PWH) have an increased risk of heart failure compared with the general population despite effective viral suppression. No methods currently exist to predict heart failure risk in PWH. We sought to develop a proteomics-based risk model of incident heart failure in a longitudinal cohort of PWH in the Veterans Aging Cohort Study Biomarker Cohort. Methods: We characterized the baseline plasma proteome of 1,398 PWH using the SomaScan 4.0 aptamer-based platform. We incorporated traditional risk factors, HIV-specific variables, and inflammatory/coagulation markers into Cox proportional hazards models of incident heart failure. For protein risk models, we used least absolute shrinkage and selection operator (LASSO) regression with 10-fold cross-validation to identify the optimal set of predictors. Model performance was evaluated using Harrell's Concordance Index (C-index). Results: Among 1,398 PWH, 240 (17.1%) developed incident heart failure over 13.1 years of median follow-up. The sample was randomly divided 2:1 into training (n = 932) and test (n = 466) sets. In the training set, 4,248 proteins were screened, identifying 227 significant markers (Bonferroni-corrected p-value <1E-5); 108 of these were validated in the test set (Bonferroni-corrected p <2E-4) and included as candidate predictors in downstream LASSO models. Using LASSO-Cox regression, we identified a subset of predictor proteins alone and in combination with clinical and laboratory risk factors. Among the clinical risk factor models, individual traditional risk factors in combination with HIV disease markers (CD4 Conclusion: An 8-protein signature demonstrated superior predictive performance for long-term incident heart failure risk among PWH compared with baseline traditional risk factors and inflammatory markers. These findings highlight the potential of a proteomics-based approach for risk stratification in this population, which provides additive value beyond traditional or HIV-specific clinical risk factors.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.